Hologic, Inc. (HOLX) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Marlborough, MA, United States. Le PDG actuel est Stephen MacMillan.
HOLX a date d'introduction en bourse 1990-03-01, 7,063 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $16.97B.
Hologic, Inc. is a global medical technology company that develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical solutions focused on women's health. Operating through four business segments—Diagnostics, Breast Health, GYN Surgical, and Skeletal Health—the company offers a comprehensive portfolio including molecular diagnostic assays for infectious disease detection, advanced breast imaging and biopsy systems, minimally invasive gynecological surgical devices, and orthopedic imaging solutions. Hologic serves healthcare providers across the United States, Europe, Asia-Pacific, and international markets through direct sales forces and independent distributors. Founded in 1985 and headquartered in Marlborough, Massachusetts, the company is committed to enabling early detection and treatment across the continuum of women's health.
